Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

103 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Guidelines for submitting adverse event reports for publication.
Kelly WN, Arellano FM, Barnes J, Bergman U, Edwards RI, Fernandez AM, Freedman SB, Goldsmith DI, Huang KA, Jones JK, McLeay R, Moore N, Stather RH, Trenque T, Troutman WG, van Puijenbroek E, Williams F, Wise RP; International Society for Pharmacoepidemiology; International Society of Pharmacovigilance. Kelly WN, et al. Among authors: trenque t. Drug Saf. 2007;30(5):367-73. doi: 10.2165/00002018-200730050-00001. Drug Saf. 2007. PMID: 17472416
Guidelines for submitting adverse event reports for publication.
Kelly WN, Arellano FM, Barnes J, Bergman U, Edwards IR, Fernandez AM, Freedman SB, Goldsmith DI, Huang K, Jones JK, McLeay R, Moore N, Stather RH, Trenque T, Troutman WG, van Puijenbroek E, Williams F, Wise RP; International Society of Pharmacoepidemiology; International Society of Pharmacovigilance. Kelly WN, et al. Among authors: trenque t. Pharmacoepidemiol Drug Saf. 2007 May;16(5):581-7. doi: 10.1002/pds.1399. Pharmacoepidemiol Drug Saf. 2007. PMID: 17471601
Guidelines for submitting adverse event reports for publication.
Kelly W, Arellano F, Barnes J, Bergman U, Edwards R, Fernandez A, Freedman S, Goldsmith D, Huang K, Jones J, McLeay R, Moore N, Stather R, Trenque T, Troutman W, van Puijenbroek E, Williams F, Wise R; International Society of Pharmacoepidemiology; International Society of Pharmacovigilance. Kelly W, et al. Among authors: trenque t. Therapie. 2009 Jul-Aug;64(4):289-94. doi: 10.2515/therapie/2009041. Epub 2009 Oct 7. Therapie. 2009. PMID: 19804709
First French experience of ADR reporting by patients after a mass immunization campaign with Influenza A (H1N1) pandemic vaccines: a comparison of reports submitted by patients and healthcare professionals.
Durrieu G, Palmaro A, Pourcel L, Caillet C, Faucher A, Jacquet A, Ouaret S, Perault-Pochat MC, Kreft-Jais C, Castot A, Lapeyre-Mestre M, Montastruc JL; French Network of Pharmacovigilance Centres. Durrieu G, et al. Drug Saf. 2012 Oct 1;35(10):845-54. doi: 10.1007/BF03261980. Drug Saf. 2012. PMID: 22967189
Drug induced stuttering: pharmacovigilance data.
Trenque T, Morel A, Trenque A, Azzouz B. Trenque T, et al. Among authors: trenque a. Expert Opin Drug Saf. 2021 Mar;20(3):373-378. doi: 10.1080/14740338.2021.1867101. Epub 2020 Dec 27. Expert Opin Drug Saf. 2021. PMID: 33337944
103 results